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Abstract
The biologic effects of visible light, particularly blue light, on the skin at doses and irradiances representative of sunlight
have been established. Recent research studies investigated the effects of blue light (BL) from electronic screen devices; however, it is unclear if the evidence can be generalized to real life. The aim of this systematic review was to evaluate available
evidence regarding clinical effects of BL emitted from electronic devices on human skin using the framework established by
the Office of Health Assessment and Translation (OHAT). A systematic literature search was conducted by two librarians in
Ovid MEDLINE, Embase.com, and Web of Science for relevant articles published from 1946 to March 2022. In vitro and
in vivo studies that investigated the effects of BL from electronic devices on skin were included. From the 87 articles gathered
from database searches and 1 article identified from citation search, only 9 met the inclusion criteria (6 in vitro and 3 in vivo
studies). Human and animal literature with the highest level of evidence ratings were considered with mechanistic data to
form one of five human hazard identifications for each outcome category using the OHAT protocol: (1) known, (2) presumed,
(3) suspected, (4) not classifiable, or (5) not identified to be a hazard to humans. Literature-based evidence integration did
not identify exposure to BL from electronic devices as a hazard to skin pigmentation, redness, yellowness, or melasma
exacerbation. Exposure to BL from electronic devices was not classified as a skin photoaging hazard. Low confidence in
representative exposure characterization drove high OHAT risk-of-bias ratings for the majority of included studies. While
these conclusions hold true for the limited existing data, a larger number of future studies with high-confidence evidence
are needed to verify and strengthen hazard identification conclusions.
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1 Introduction
The visible light (VL; 400 to 700 nm) portion of the solar
spectrum can induce long-lasting skin pigmentation in dark
skin types (Fitzpatrick skin types [FSTs] IV–VI) and erythema in light skin types (FSTs I–III) through the production of free radicals [1–3]. Additionally, certain pathologies
such as melasma, post-inflammatory hyperpigmentation,
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and photodermatoses are exacerbated by VL exposure [4].
Of note, the effects of VL are determined by its intensity
and wavelength. Shorter wavelengths of visible light, particularly wavelengths close to ultraviolet A (blue-violet
415 nm), were shown to dose-dependently generate free
radicals and stimulate skin pigmentation under irradiation
conditions similar to natural sun exposure [5, 6]. While sunlight is the primary source of blue light (BL) at ground level,
low-intensity BL (with irradiance approximately 1000 times
lower than that of the corresponding natural sunlight) can be
generated by other sources, including screens of electronic
devices [7]. In addition to producing a lower intensity BL
than the sun, dominant BL wavelengths emitted by most
electronic devices do not contain the shorter and more energetic 415 nm wavelength [7–9].
With the increased exposure to electronic screens in
recent years, there is a growing interest in the effects of
their low-intensity BL emissions on the skin. This is supported by frequent features in the media and many photoprotection products claiming defense against BL [10–13].
As such, recent publications discuss the results regarding
the impact of BL emitted from electronic devices on the skin
[7–9, 14–19]. Of note, due to unavailability of validated and
standardized phototesting guidelines against VL and BL,
study protocols and exposures varied greatly. This makes it
challenging to interpret the results into clinical significance.
The objective of this systematic review was to comprehensively evaluate the literature investigating the effects of BL
from electronic devices on the skin in vivo and in vitro and
determine the level of evidence for a hazardous effect on
humans by closely following the framework established by
the Office of Health Assessment and Translation (OHAT).

2 Methods
2.1 Focused question and protocol registration
This focused question was: “Does BL emitted from electronic devices have clinical effects on human skin?” This
review was registered with the Prospective Register of
Systematic Reviews (PROSPERO) and followed the Preferred Reporting Items for Systematic Reviews (PRISMA)
guidelines.

2.2 Search strategy
Ovid MEDLINE, Embase.com, and Web of Science databases were searched by two independent librarians from
1946 to March 10, 2022. Individual search strings used for
each database is included in Supplemental Fig. 1. Reference
lists of relevant articles were hand searched for additional
articles.
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2.3 Eligibility criteria
This review included studies in English that evaluated
exposure to BL emitted from electronic device screens or
aimed to simulate such an exposure. We included in vitro
studies on human or animal cell lines and in vivo studies
on human or animal skin. Articles were included if the
measurement of biological and clinical outcomes related to
skin pigmentation, skin redness, skin yellowness, or skin
photoaging occurred following exposure to the light source.
We excluded abstract only papers, opinion/communication,
narrative reviews, systematic reviews, and meta-analyses.

2.4 Article selection & data extraction
Based on eligibility criteria, titles and abstracts of all articles were screened and full-text review of eligible texts
were subsequently performed. Two authors (MC and JP)
independently reviewed all the records and extracted data
from included studies. Consensus was determined by a third
author (IK).
The following relevant information was collected from
eligible studies: (1) publication details (first author, year,
country, funding sources, and possible and reported conflicts
of interest), (2) study design, (3) qualities of test and control
samples/substrates (number, conditions, source, eligibility
criteria), (4) aims, (5) primary and ancillary endpoints, (5)
assessment methods, and (6) lowest level of exposure for
outcomes. Light source parameters were extracted based on
the recommendations for reporting methods in phototesting studies and included: (1) light source type, (2) exposure waveband (nm), (3) filter, (4) calibration method, (5)
distance between light source and sample/substrate, (6)
irradiation time, (7) number of exposures and frequency,
(8) individual and cumulative doses (J/cm2), and (9) irradiance [20]. Covidence, a web-based platform for systematic
review management, was used to organize the articles and
data extraction.

2.5 Risk of bias assessment and evidence
integration
The Office of Health Assessment and Translation (OHAT)
framework for determination of potential hazardous health
effects from exposure to environmental substances was
used to integrate the evidence obtained from the systematic
review process into conclusions. The sequence of OHAT
steps followed after data extraction from studies included in
the systematic review were: (1) critically assess individual
studies for risk of bias (all included studies), (2) synthesize
confidence in the results of included studies (in vivo: human
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and animal), (3) translate the confidence ratings into levels
of evidence (in vivo: human and animal), and (4) develop
hazard identification conclusions (all included studies) [21].
Inclusion of studies in each step was according to OHAT
recommended guidelines. Evidence from human and animal
studies were assessed separately and integrated in the last
step [22]. Methodology for each of the four OHAT-specific
steps is discussed below:
(1) Risk of bias assessment: individual studies
	  All included studies were separated by study design
and independently assessed for risk of bias by two
authors (MC and JP) with consensus formed by a third
author (IK). Applicable OHAT risk of bias questions
relevant to the design of each study were rated on a
four-point scale: definitely low risk (++), probably
low risk (+), not reported/probably high risk (-), and
definitely high risk (–) [21–23]. Following this, a threetier approach was used to determine individual study
quality based on the risk of bias question ratings with
emphasis on project-specific key study elements, which
for this review were regarding confidence in exposure
characterization, outcome assessment, and consideration of important confounding variables. Tier grading
criteria are described in Supplemental Table 1. Optimally, Tier 3 studies, which have a high concern of
bias on key elements, should be excluded from further
analysis; however, considering the limited number of
relevant studies all available in vivo data was considered for analysis in the next step [22].
(2) Forming confidence ratings in bodies of evidence
	  Following the OHAT framework to determine the
confidence in the bodies of evidence, an initial confidence rating of high (++++), moderate (+++), low
(++), or very low (+) was assigned to each outcome
evaluated in the included human and animal studies
based on the number of the following study design features: controlled exposure, exposure prior to outcome,
individual outcome data, and use of comparison group.
Then, this initial confidence rating was downgraded
one level for each factor weakening confidence (risk
of bias, unexplained inconsistency, indirectness, lack
of applicability, imprecision, and publication bias) and
upgraded one level each for each factor strengthening
confidence (large magnitude of effect, dose response,
consistency across dissimilar evidence streams, and
consideration of residual confounders). Resulting evidence with a very low confidence rating (+) was not
considered for the next step [21, 22].
(3) Translation into evidence of health effects
	  The resulting confidence ratings from each body of
evidence from the previous step were translated into
corresponding evidence ratings for each health effect.

Studies showing evidence of a health effect were given
an evidence rating of high, moderate, or low based on
their respective confidence level in the body of evidence. For studies showing no health effect, the level
of evidence was translated into evidence of no health
effect (high confidence in body evidence) or inadequate
evidence (moderate and low confidence in body of
evidence). Outcomes from the previous step were first
assessed separately before similar outcomes were considered together to determine the overall confidence in
the association between exposure and the health effect
[21].
(4) Develop hazard identification
In the last step, one of five hazard identification conclusions (known, presumed, suspected, not classifiable,
not identified) for health effects to humans is developed.
Hazard identification is formed by integrating the level of
evidence for health effects in human and animal studies
determined in the prior step, which then can be upgraded
or downgraded depending on the strength of relevant
mechanistic in vitro data [21, 22].

2.6 Statistical analysis
The analyses of this study involved implementation of the
OHAT framework on the data extracted from the included
articles to evaluate evidence for potential hazardous health
effects of BL from electronic device screens on human
skin. Use of statistical tests was not applicable.

3 Results
3.1 Included studies
A total of 87 studies were identified from databases and
processed according to the PRISMA statement (Fig. 1).
After de-duplication, 54 articles were screened by title
and abstract, which identified 28 studies that did not meet
eligibility criteria. Full-text review of 26 articles excluded
18 studies for the following reasons: abstract only (n = 12),
review paper (n = 2), inapplicable aim (n = 1), inapplicable substrate (n = 1), communication (n = 1), and retracted
paper (n = 1). A total of one record was identified by citation search, assessed for eligibility, and included in the
review. Thus, a grand total of nine studies from both database and citation searches were included for data extraction, qualitative analysis, risk assessment, and hazard identification conclusions.
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Fig. 1  PRISMA 2020 flow diagram for systematic study selection

3.2 General study features
General study qualities that were extracted from the
included studies are summarized in Supplemental Table 2.
Of the nine included articles, six conducted in vitro
studies and three conducted in vivo human studies. There
were zero in vivo animal studies. Eight studies (89%) were
non-randomized experimental studies while one (11%) was
randomized. Studies were conducted in the USA, France,
Korea, Spain, Italy, and Monaco and published between
2018 and 2021.
The six in vitro studies performed experiments on
multiple sample types, with some studies using more than
one form. Studies used human-derived fibroblasts (n = 5),
human-derived keratinocytes (n = 2), murine-derived
melanocytes (n = 2), and skin explants (n = 1). The three
in vivo studies performed experiments on the skin located
on the back (n = 2) and the face (n = 1) of female adults
with FST III–IV. Within the six vitro studies, primary biologic endpoints included reactive oxygen species (ROS),
DNA damage, mitochondrial damage, cellular viability,
cytoskeleton damage, and hyperpigmentation. The three
in vivo studies had primary biologic endpoints of hyperpigmentation, redness, yellowness, erythema, and photoaging. Outcomes were measured using the L*a*b* values,
individual typography angle (ITA), minimum persistent
pigment darkening dose (MPPD), melanin index, modified
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melasma area and severity (mMASI) score, erythema
index, transparency, skin hydration, and elasticity.

3.3 Blue light irradiation parameters
Light source parameters and irradiation procedures varied
among the nine included studies and are summarized in Supplemental Table 3. To study the effects of BL, seven (77.8%)
studies used light-emitting diode (LED) lights, one used filtered light from a xenon solar simulator, and one used multiple electronic devices. Seven (77.8%) studies exclusively
studied wavelengths only within the BL spectrum with peaks
ranging within 415–490 nm. Two (22.2%) studies investigated BL effects by using broad-spectrum sources including
wavelengths beyond BL, as one used the VL and infrared
spectrum (420 to 1072 nm) and one used blue, green, and
red wavelengths (450 nm, 525 nm, and 625 nm). Calibration method was reported in four (44.4%) studies, where
a photometer, spectroradiometer, optical power meter, and
power meter intensities were used. Irradiance of BL was
reported in four (44.4%) studies and could be calculated
from reported parameters in three (33.3%) studies, which
ranged from 0.207 to 112 mW/cm2. Eight (88.9%) studies
had one exposure and one (12.5%) study had five exposures
over 5 days. Single and multiple exposures led to cumulative
BL doses that ranged from 0.7452 to 1597 J/cm2 with some
corresponding to BL only and some to BL within the broadband source. The distance between light source and sample/
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substrate was reported in four (44.4%) studies, in which two
studies placed the light source directly below the cell culture
plate, one study placed the light source 1 cm from the cell
plate, and one study placed the subject 20 cm away from the
light source. The duration of exposure was reported in four
(44.4%) studies and ranged from 15 min to 3 h.

3.4 Relevant outcomes
Hazardous human health effects of BL emitted from electronic devices were depicted in all six in vitro studies and
two of three in vivo studies. Specific outcomes examined in
included studies are summarized below and in Supplemental
Table 4.
(1) Outcomes evaluated by in vitro studies
Increased production of ROS was the first effect observed
with the lowest dose of BL, which was 0.7452 J/cm2 from
an Apple iPad that emitted a total VL + infrared (IR) dose
of 3.06 J/cm2 [8]. Increased ROS production was measured
in three studies using dihydrorhodamine-123 (DHR-123)
flow cytometry (n = 1), 2',7'-dichlorodihydrofluorescein
diacetate (H2-DCFDA) oxidation (n = 1), and dihydrofluorescein diacetate (DHFDA) fluorescent microscopy (n = 1)
[8, 14, 18]. Increased DNA damage was found by three studies: one study found increased olive tail moment (OTM)
distributions, increased cyclobutane–pyrimidine dimers
(CPD) lesions, slower time-dependent repair, and increased
number of micronucleated cells, one study found increased
8-dihydroxy-2'-deoxyguanosine (8-OHdG) production, and
one study found increased light-modulated transcripts from
human genome microarray-based gene expression analysis
[9, 14, 15]. Five studies evaluated the effects on cell viability. One study did not find significant changes in apoptosis and necrosis using FlowCellect Annexin Red Kit flow
cytometry [8]. Decreased cellular viability was found in four
studies using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl2H-tetrazolium bromide (MTT) assays (n = 4), adenosine
5-triphosphate (ATP) levels (n = 1), and population doubling
times (n = 1) [9, 14, 18, 19]. Increased mitochondrial effects
were found in three studies by using mitochondrial network
length (n = 1), irregular morphology (n = 3), and membrane
potential hyperpolarization (n = 2) [9, 18, 19]. Disorganized
cytoskeletal effects were determined with F-actin organization and cell spreading image analysis in one study [9].
Increased degradation of extracellular matrix mRNA and
protein components were assessed in two studies from
increased expression of matrix metalloproteinase-1 (n = 1),
matrix metalloproteinase-12 (n = 1) and down-regulation of
pro-collagen type 1 (n = 1) and collagen type 1 (n = 1) [9,
14]. Hyperpigmentation was assessed in one study by measuring increased darkening of extracellular and intracellular

pigments [19]. Two studies evaluated signal transduction
outcomes, as one found increased activation of p38 melanogenic signaling pathway and one study found increased
activation of mitogen-activated protein kinase p38 phosphorylation and increased opsin-3 expression [18, 19].
(2) Outcomes evaluated by in vivo studies
All three in vivo studies evaluated the effects of BL from
electronic devices on FST III–IV female adult skin, among
these was one study on subjects with melasma. One study
had irradiance information available, while irradiance was
not reported (NR) and could not be calculated from given
parameters for the parts of the other two studies included in
this review. All three studies evaluated skin pigmentation
effects. One study did not find a significant change in skin
pigmentation as assessed by delta L* or delta ITA in melasma patients with a BL dose of 0.865 J/cm2 BL administered at an irradiance of 0.48 mW/cm2 [7]. Both of the other
two studies found significant pigmentary changes: one found
changes in L* and melanin index with the effect induced
at 447 J/cm2 (irradiance NR) [16] and the other obtained
changes in melanin index and three-point visual examination
score with a BL dose of 135 J/cm2 (irradiance NR) [17].
Two studies assessed skin redness and yellowness by
measuring delta a* and delta b*, where one study observed
958 J/cm2 and 1597 J/cm2 as the lowest doses to exert a
significantly increased delta a* and delta b*, respectively
(irradiance NR) [16]. The other study did not find a significant change in delta a* or delta b* with a BL dose of 0.864 J/
cm2 using 0.48 mW/cm2 irradiance [7]. One study measured the erythema index, which had a significant increase
at a 447 J/cm2 BL dose (irradiance NR) [16]. One study
measured disease activity of melasma using the change in
mMASI, where no significant effect was observed using a
single BL dose of 0.865 J/cm2 or cumulative 5-day BL dose
of 4.43 J/cm2 performed at an irradiance of 0.48 mW/cm2
[7]. One study measured the skin photoaging qualities of
transparency, hydration, and elasticity and an increase in all
photoaging parameters was found at the lowest BL dose of
446 J/cm2 (irradiance NR) [16].

3.5 Quality assessment and hazard identification
conclusions
(1) Bias assessment of individual studies
Figure 2 shows individual study ratings for each risk-ofbias question that applied to its study design according to
the OHAT tool. Across all study types, one (11.1%) study
was rated as Tier 1, indicating the lowest risk of bias. Four
studies (44.4%) were rated as Tier 2 and four (44.4%) studies
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Fig. 2  Quality assessment ratings for individual studies. ++ : definitely low risk of bias, + : probably low risk of bias, -: NR/ not reported/probably high risk of bias, –: definitely high risk of bias, *key features considered in tier criteria

were rated as Tier 3. Out of the three in vivo studies, there
was one (33.3%) Tier 1 study, which had a “definitely low”
risk of bias in all applicable domains, and two (66.6%) Tier
3 studies. Nonetheless, Tier 3 evidence was considered for
further analysis due to a limited number of included in vivo
studies. Zero (0%) in vitro studies had a “definitely low” or
“probably low” risk of bias in all applicable domains.
(2) Confidence in the bodies of evidence
Three human studies, which included two Tier 3 studies, were considered in the body of evidence confidence
rating for each health outcome. No animal studies were

considered, as none were found in included articles. Mechanistic in vitro studies were not included in this step, per
OHAT handbook [22]. Table 1 shows the final confidence
levels in the body of evidence for the four main clinical
outcomes: skin pigmentation (high confidence, ++++),
skin redness and yellowness (high confidence, ++++),
melasma exacerbation (high confidence, ++++), and skin
photoaging (low confidence, ++). Supplemental Table 5
contains further details involved in determination of these
confidence ratings and factors that upgraded or downgraded the confidence of each outcome by one level for
each factor. All studies had an initial confidence rating of
high (++++).

Table 1  Confidence ratings and hazardous identifications determined by the OHAT framework
Health effect

Confidence in body Effect direction (Step 3) Level of evidence for health
of evidence (Step 2)
effect (Step 3)

Hazard identification conclusions
(Step 4)

Skin pigmentation

++++

No effect

Evidence of no health effect

Skin redness/yellowness ++++

No effect

Evidence of no health effect

Melasma exacerbation

++++

No effect

Evidence of no health effect

Skin photoaging

++

Health effect

Low level of evidence for health
effect

Not identified to be a hazard to
humans
Not identified to be a hazard to
humans
Not identified to be a hazard to
humans
Not classifiable to be a hazard to
humans

  ++++ : high confidence
+++ : moderate confidence
++ : low confidence
+ : very low confidence
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(3) Health effects
Health effects are summarized in Table 1 and detailed in
Supplemental Table 5. The evidence with high-level confidence showed BL from electronic devices did not have a
health effect on skin pigmentation, skin redness, skin yellowness, and melasma exacerbation. Evidence with lowlevel confidence showed that BL from electronic devices
did have a photoaging health effect.
(4) Hazard identification
Final hazard identification conclusions are summarized
in Table 1. BL from electronic devices was not identified
as a hazard to human skin pigmentation, skin redness, skin
yellowness, or melasma exacerbation, as high-level evidence
did not find these health effects. BL was not classifiable as a
hazard to human skin photoaging due to associated evidence
having low-level confidence. In vitro data did not provide
strong evidence to support upgrading the hazard identification conclusion for skin photoaging.

3.6 Discussion
Based on the current literature, BL from electronic devices
was not determined a hazard to human skin pigmentation,
redness, yellowness, or melasma activity and was not classifiable as a hazard to human skin photoaging. Apart from
photoaging, which was based on Tier 3 evidence, these conclusions were determined from studies with the highest level
of evidence.
The level of confidence in studies was primarily affected
by irradiation exposure parameters and choice of tested substrate, which varied significantly among the included studies. Findings representative or suggestive of negative health
effects were found frequently among bodies of evidence
that received a low confidence rating. This was primarily
influenced by low confidence in exposure characterization
in the OHAT risk-of-bias ratings. Electronic devices emit
BL at a very low irradiance, approximately 30 µW/cm2 [7].
However, most of the included studies used irradiances two
to three orders of magnitude greater [7, 9]. The findings, as
such, should be interpreted with caution. These studies may
have utilized high irradiances to recreate long-term exposure
in a shortened amount of time [24]. With VL phototesting
still being a relatively new area of study, standard guidelines
for testing are not yet in place. Therefore, until appropriate testing ranges are established, irradiation parameters
in study protocols must be deliberatively chosen to mimic
irradiation levels of actual electronic devices as closely as
possible to obtain clinically relevant results.

Outcomes indicative of negative health effects were found
among all included in vitro studies. However, findings of
in vitro studies are not intended to identify a disease phenotype. Rather, they are meant to detect cellular, biochemical,
and molecular processes or early biomarkers [22]. For this
reason, mechanistic data from in vitro studies is integrated in
the last OHAT step, rather than during determination of confidence in the body of evidence for each health effect outcome
[22]. Additionally, in vitro studies may be more sensitive to
interventions, such as irradiation, as structural integrity, barrier
function, and physiologic repair mechanisms are not maintained [25]. In vitro studies also cannot account for FST, which
is an important factor to consider, as VL primarily exerts clinical changes on FST IV–VI skin [1].
Findings of this study suggest the established effects on skin
by BL from sunlight are not induced by the low-intensity BL
from electronic devices [1, 3, 5, 26]. As such, based on available evidence, we do not consider it necessary to use sunscreen
protective against blue light while using electronic devices
indoors in a room without sunlight from a window. Clinicians
and consumers should be aware of the clinically unsupported
claims of skin photodamage induced by BL from electronic
devices. This information can be used to guide patients on the
environmental conditions that require photoprotection, lifestyle
practices, and purchase of evidence-based skin care products.

3.7 Conclusion
Using the OHAT approach for systematic review and integration of the current evidence, BL from electronic devices was
not identified as a hazard to human skin pigmentation, redness,
yellowness, and exacerbation of melasma. BL from electronic
devices was not classifiable as a hazard to human photoaging.
A larger number of future studies with minimal bias and exposure levels representative of electronic devices is warranted to
verify and strengthen these hazard identification conclusions.
Supplementary Information The online version contains supplementary material available at https://d oi.o rg/1 0.1 007/s 43630-0 22-0 0318-9.
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